Detalhe da pesquisa
1.
Signaling by Antibodies: Recent Progress.
Annu Rev Immunol
; 35: 285-311, 2017 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-28446061
2.
Bispecific dendritic-T cell engager potentiates anti-tumor immunity.
Cell
; 187(2): 375-389.e18, 2024 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38242085
3.
BCR affinity differentially regulates colonization of the subepithelial dome and infiltration into germinal centers within Peyer's patches.
Nat Immunol
; 20(4): 482-492, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30833793
4.
Type I and type II Fc receptors regulate innate and adaptive immunity.
Nat Immunol
; 15(8): 707-16, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25045879
5.
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors.
Immunity
; 46(4): 577-586, 2017 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28410988
6.
Artificial Antigen Presenting Cells for Detection and Desensitization of Autoreactive T cells Associated with Type 1 Diabetes.
Nano Lett
; 22(11): 4376-4382, 2022 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35616515
7.
Toxicity of an Fc-engineered anti-CD40 antibody is abrogated by intratumoral injection and results in durable antitumor immunity.
Proc Natl Acad Sci U S A
; 115(43): 11048-11053, 2018 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30297432
8.
HLA-DRα1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitis.
J Immunol
; 192(9): 4164-73, 2014 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24683185
9.
FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment.
Cancer Immunol Res
; 12(3): 322-333, 2024 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38147316
10.
Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocols.
Nat Cancer
; 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38429414
11.
Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitope.
J Autoimmun
; 47: 83-93, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24090977
12.
A novel regulatory pathway for autoimmune disease: binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell tolerance.
J Autoimmun
; 40: 96-110, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23026773
13.
Fc glycoengineering of a PD-L1 antibody harnesses Fcγ receptors for increased antitumor efficacy.
Sci Immunol
; 8(81): eadd8005, 2023 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36867679
14.
FcyRIIB is a novel immune checkpoint in the tumor microenvironment limiting activity of Treg-targeting antibodies.
bioRxiv
; 2023 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36711504
15.
TCR-like antibodies distinguish conformational and functional differences in two- versus four-domain auto reactive MHC class II-peptide complexes.
Eur J Immunol
; 41(5): 1465-79, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21469129
16.
T-cell-receptor-like antibodies - generation, function and applications.
Expert Rev Mol Med
; 14: e6, 2012 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-22361332
17.
Next Generation CD40 Agonistic Antibodies for Cancer Immunotherapy.
Front Immunol
; 13: 940674, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35911742
18.
Bispecific antibodies increase the therapeutic window of CD40 agonists through selective dendritic cell targeting.
Nat Cancer
; 3(3): 287-302, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35190724
19.
Therapeutic antibody activation of the glucocorticoid-induced TNF receptor by a clustering mechanism.
Sci Adv
; 8(8): eabm4552, 2022 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35213218
20.
Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern.
Cell Rep
; 37(11): 110114, 2021 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34883043